Conning Inc’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.83M | Sell |
65,223
-3,795
| -5% | -$101K | 0.06% | 156 |
|
|
2025
Q4 | $1.72M | Buy |
69,018
+148
| +0.2% | +$3.73K | 0.06% | 169 |
|
|
2025
Q3 | $1.75M | Hold |
68,870
| – | – | 0.06% | 168 |
|
|
2025
Q2 | $1.67M | Sell |
68,870
-1,596
| -2% | -$37.2K | 0.06% | 160 |
|
|
2025
Q1 | $1.79M | Sell |
70,466
-372
| -0.5% | -$9.73K | 0.06% | 156 |
|
|
2024
Q4 | $1.88M | Sell |
70,838
-6,248
| -8% | -$169K | 0.07% | 149 |
|
|
2024
Q3 | $2.23M | Sell |
77,086
-1,823
| -2% | -$53.2K | 0.07% | 143 |
|
|
2024
Q2 | $2.21M | Sell |
78,909
-65,728
| -45% | -$1.81M | 0.08% | 140 |
|
|
2024
Q1 | $4.01M | Sell |
144,637
-1,063,488
| -88% | -$29.5M | 0.13% | 121 |
|
|
2023
Q4 | $34.7M | Buy |
1,208,125
+142,872
| +13% | +$4.32M | 1.21% | 26 |
|
|
2023
Q3 | $35.3M | Buy |
1,065,253
+83,876
| +9% | +$2.97M | 1.29% | 15 |
|
|
2023
Q2 | $35.9M | Buy |
981,377
+22,357
| +2% | +$870K | 1.2% | 33 |
|
|
2023
Q1 | $39.1M | Buy |
959,020
+157,925
| +20% | +$6.82M | 1.31% | 12 |
|
|
2022
Q4 | $41M | Sell |
801,095
-37,029
| -4% | -$1.78M | 1.33% | 4 |
|
|
2022
Q3 | $36.6M | Sell |
838,124
-85,272
| -9% | -$4.14M | 1.3% | 8 |
|
|
2022
Q2 | $48.4M | Sell |
923,396
-101,235
| -10% | -$5.16M | 1.45% | 4 |
|
|
2022
Q1 | $53M | Buy |
1,024,631
+33,383
| +3% | +$1.73M | 1.44% | 4 |
|
|
2021
Q4 | $58.5M | Sell |
991,248
-194,026
| -16% | -$9.61M | 1.56% | 5 |
|
|
2021
Q3 | $50.9M | Sell |
1,185,274
-231,306
| -16% | -$10.2M | 1.46% | 12 |
|
|
2021
Q2 | $55.4M | Sell |
1,416,580
-109,690
| -7% | -$4.27M | 1.61% | 5 |
|
|
2021
Q1 | $55.3M | Buy |
1,526,270
+216,599
| +17% | +$7.69M | 1.66% | 5 |
|
|
2020
Q4 | $48.2M | Sell |
1,309,671
-23,703
| -2% | -$869K | 1.53% | 21 |
|
|
2020
Q3 | $46.4M | Buy |
1,333,374
+64,866
| +5% | +$2.27M | 1.63% | 6 |
|
|
2020
Q2 | $39.4M | Sell |
1,268,508
-152,145
| -11% | -$5.17M | 1.46% | 29 |
|
|
2020
Q1 | $44M | Buy |
1,420,653
+50,526
| +4% | +$1.72M | 1.87% | 9 |
|
|
2019
Q4 | $50.9M | Buy |
1,370,127
+43,079
| +3% | +$1.53M | 1.67% | 11 |
|
|
2019
Q3 | $45.2M | Buy |
1,327,048
+164,829
| +14% | +$5.99M | 1.57% | 15 |
|
|
2019
Q2 | $47.8M | Sell |
1,162,219
-51,925
| -4% | -$2.06M | 1.58% | 6 |
|
|
2019
Q1 | $48.9M | Buy |
1,214,144
+30,837
| +3% | +$1.23M | 1.53% | 11 |
|
|
2018
Q4 | $49M | Sell |
1,183,307
-150,915
| -11% | -$6.26M | 1.67% | 5 |
|
|
2018
Q3 | $55.8M | Sell |
1,334,222
-96,432
| -7% | -$3.71M | 1.65% | 5 |
|
|
2018
Q2 | $49.2M | Buy |
1,430,654
+53,225
| +4% | +$1.82M | 1.5% | 9 |
|
|
2018
Q1 | $46.4M | Buy |
1,377,429
+121,107
| +10% | +$4.16M | 1.49% | 8 |
|
|
2017
Q4 | $43.2M | Sell |
1,256,322
-12,268
| -1% | -$418K | 1.43% | 7 |
|
|
2017
Q3 | $43M | Buy |
1,268,590
+14,588
| +1% | +$469K | 1.46% | 7 |
|
|
2017
Q2 | $40M | Buy |
1,254,002
+42,144
| +3% | +$1.33M | 1.45% | 5 |
|
|
2017
Q1 | $39.3M | Buy |
1,211,858
+90,564
| +8% | +$2.86M | 1.45% | 7 |
|
|
2016
Q4 | $34.6M | Sell |
1,121,294
-25,852
| -2% | -$789K | 1.38% | 11 |
|
|
2016
Q3 | $36.9M | Buy |
1,147,146
+8,320
| +0.7% | +$278K | 1.47% | 11 |
|
|
2016
Q2 | $38M | Sell |
1,138,826
-112,095
| -9% | -$3.58M | 1.57% | 7 |
|
|
2016
Q1 | $35.2M | Buy |
1,250,921
+46,851
| +4% | +$1.34M | 1.48% | 9 |
|
|
2015
Q4 | $36.9M | Sell |
1,204,070
-3,275
| -0.3% | -$103K | 1.58% | 7 |
|
|
2015
Q3 | $36M | Buy |
1,207,345
+14,067
| +1% | +$451K | 1.58% | 6 |
|
|
2015
Q2 | $38M | Sell |
1,193,278
-18,826
| -2% | -$614K | 1.56% | 6 |
|
|
2015
Q1 | $40M | Buy |
1,212,104
+224,536
| +23% | +$7.14M | 1.7% | 2 |
|
|
2014
Q4 | $29.2M | Buy |
987,568
+17,637
| +2% | +$506K | 1.42% | 11 |
|
|
2014
Q3 | $27.2M | Buy |
969,931
+30,794
| +3% | +$864K | 1.43% | 11 |
|
|
2014
Q2 | $26.4M | Buy |
939,137
+124,081
| +15% | +$3.54M | 1.41% | 10 |
|
|
2014
Q1 | $24.8M | Buy |
815,056
+19,594
| +2% | +$584K | 1.46% | 9 |
|
|
2013
Q4 | $23.1M | Buy |
795,462
+520,362
| +189% | +$15.1M | 1.43% | 10 |
|
|
2013
Q3 | $7.5M | Sell |
275,100
-1,571
| -0.6% | -$42.7K | 0.58% | 58 |
|
|
2013
Q2 | $7.35M | Buy |
+276,671
| New | +$7.64M | 0.61% | 56 |
|
Other funds holding PFE
VCM
VPM
Conning Inc's PFE Position: Q1 2026 in Review
Conning Inc reduced its Pfizer (PFE) stake by 5.5% in Q1 2026, selling an estimated $101K and leaving 65,223 shares worth $1.83M. The position accounts for 0.06% of the portfolio, ranked #156.
Conning Inc first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $58.5M in Q4 2021. 2,939 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Conning Inc held 65,223 shares of Pfizer worth $1.83M as of Q1 2026.
- Conning Inc sold 3,795 Pfizer shares in Q1 2026, an estimated $101K.
- Pfizer made up 0.06% of Conning Inc's portfolio in Q1 2026, its #156 holding.
- Conning Inc first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
- Conning Inc's Pfizer position peaked at $58.5M in Q4 2021.
- 2,939 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Conning Inc's 13F filing for Q1 2026, filed 30 Apr 2026.